ERBB2 and breast carcinoma: In parallel, our data also demonstrate that high consecrations of EA trigger apoptosis, particularly in breast cancer cells, which is associated with Bcl-2/Bax/caspase-3 signaling pathway in HER2-positive cancer cells.